Search results for: 'made fuels develop deceleration'

13 Nov 2017  |  Asia Pacific  |  Market Research

Growth Opportunities in the Chinese Fuel Additives Market

Focus Products—Lubricity Improvers and Cold Flow Additives for Diesel

Infographics

×

The Chinese diesel market is set to grow at a robust pace over the next 5 to 7 seven years as production of diesel vehicles increases and the introduction of China V specifications takes center stage. The implementation of China V regulations is key to the consumption of diesel, and in turn, lubricity improvers (LI) and cold flow (CF) additives. Lu...

Innovations in logistics are aplenty with APAC fueling a lot of this activity from its home ground. From self-running trucks to automated contracts, the supply chain is ripe for innovation and homegrown APAC start-ups are plowing the way. The market is seeing the rise of these new breed of participants along key future themes, including artificial ...

This study provides insights into key mega trends for the buildings sector in Asia-Pacific. Global mega trends such as urbanization and economic and technological development are changing the demographics and financial outlook in Asia-Pacific, and will shape the region’s buildings sector. The trends examined are, broadly, building construction, and...

10 Dec 2015  |  Asia Pacific  |  Megatrends

Top 10 Smart Cities of Asia-Pacific by 2025

An Overview of the smart city landscape

Infographics

×

Asia-Pacific is a frontier of growth, development, and activity having quickly embraced disruptive trends in its journey to grow. This ecosystem depicts an eclectic mix of cities. This research service explores the dynamics, plans, and trends in the developments of smart cities in the Asia-Pacific region. It explores how governments, companies, and...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...